Platelets and endothelial cells

Seminars in Thrombosis and Hemostasis

Volumn 33, Issue 2, 2007, Pages 128-135

  Siegel Axel, Dorothea I ^a   Gawaz, Meinrad ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Adhesion molecules; Atherothrombosis; Endothelial cells; Interactions; Platelets

Indexed keywords

ABCIXIMAB; ANTILIPEMIC AGENT; HYPOCHOLESTEROLEMIC AGENT; PADGEM PROTEIN;

ACUTE HEART INFARCTION; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL COMMUNICATION; CELL FUNCTION; CELL INTERACTION; DIET THERAPY; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; HUMAN; PARACRINE SIGNALING; PATHOGENESIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREDICTION; PRIORITY JOURNAL; REVIEW; STENT; THROMBOCYTE; THROMBOCYTE ADHESION; THROMBOCYTE FUNCTION; TRANSLUMINAL CORONARY ANGIOPLASTY;

ARTERIAL OCCLUSIVE DISEASES; BLOOD PLATELETS; CELL ADHESION; CELL COMMUNICATION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; THROMBOSIS;

EID: 33947219561     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-969025     Document Type: Review

References (65)

1. Tan KT, Watson SP, Lip GY. The endothelium and platelets in cardiovascular disease: potential targets for therapeutic intervention. Curr Med Chem Cardiovasc Hematol Agents 2004;2:169-178
2. McGregor L, Martin J, McGregor JL. Platelet-leukocyte aggregates and derived microparticles in inflammation, vascular remodelling and thrombosis. Front Biosci 2006;11: 830-837
3. Weber C. Platelets and chemokines in atherosclerosis: partners in crime. Circ Res 2005;96:612-616
4. Cines DB, Pollak ES, Buck CA, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998;91:3527-3561
5. Augustin HG, Kozian DH, Johnson RC. Differentiation of endothelial cells: analysis of the constitutive and activated endothelial cell phenotypes. Bioessays 1994;16:901-906
6. Stouffer GA, Smyth SS. Effects of thrombin on interactions between beta3-integrins and extracellular matrix in platelets and vascular cells. Arterioscler Thromb Vasc Biol 2003;23: 1971-1978
7. Harker LA, Roskos LK, Marzec UM, et al. Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers. Blood 2000;95:2514-2522
8. Warkentin TE, Aird WC, Rand JH. Platelet-endothelial interactions: sepsis, HIT, and antiphospholipid syndrome. Hematology (Am Soc Hematol Educ Program) 2003:497-519
9. Sachais BS. Platelet-endothelial interactions in atherosclerosis. Curr Atheroscler Rep 2001;3:412-416
10. Li G, Sanders JM, Phan ET, et al. Arterial macrophages and regenerating endothelial cells express P-selectin in atherosclerosis-prone apolipoprotein E-deficient mice. Am J Pathol 2005;167:1511-1518
11. Gross PL, Aird WC. The endothelium and thrombosis. Semin Thromb Hemost 2000;26:463-478
12. Kinlay S, Libby P, Ganz P. Endothelial function and coronary artery disease. Curr Opin Lipidol 2001;12:383-389
13. Tailor A, Granger DN. Role of adhesion molecules in vascular regulation and damage. Curr Hypertens Rep 2000;2: 78-83
14. Sixma JJ, Wester J. The hemostatic plug. Semin Hematol 1977;14:265-299
15. Langer H, Gawaz M. The coagulation cascade-clinical implications. Herz 2005;30:170-175
16. Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002; 8:1227-1234
17. Gawaz M. Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium. Cardiovasc Res 2004;61:498-511
18. Choi K. The hemangioblast: a common progenitor of hematopoietic and endothelial cells. J Hematother Stem Cell Res 2002;11:91-101
19. Denis CV. Molecular and cellular biology of von Willebrand factor. Int J Hematol 2002;75:3-8
20. Lin Y, Weisdorf DJ, Solovey A, et al. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000;105:71-77
21. Langer H, Gawaz M. The role of platelets for the pathophysiology of acute coronary syndromes. Hamostaseologic 2006;26:114-118
22. Ruggeri ZM. Platelet interactions with vessel wall components during thrombogenesis. Blood Cells Mol Dis 2006; 36:145-147
23. Ruggeri ZM. Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost 2003;1:1335-1342
24. Massberg S, Gawaz M, Gruner S, et al. A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med 2003;197:41-49
25. Bennett JS. Novel platelet inhibitors. Annu Rev Med 2001;52:161-184
26. Turitto VT, Weiss HJ, Zimmerman TS, et al. Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion. Blood 1985;65:823-831
27. Coller BS, Peerschke EI, Scudder LE, et al. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood 1983;61:99-110
28. Back LD, Radbill JR, Crawford DW. Analysis of pulsatile, viscous blood flow through diseased coronary arteries of man. J Biomech 1977;10:339-353
29. Andrews RK, Berndt MC. Platelet physiology and throm-bosis. Thromb Res 2004;114:447-453
30. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005;115:3378-3384
31. Steinhubl SR, Moliterno DJ. The role of the platelet in the pathogenesis of atherothrombosis. Am J Cardiovasc Drugs 2005;5:399-408
32. Schwarz UR, Kobsar AL, Koksch M, et al. Inhibition of agonist-induced p42 and p38 mitogen-activated protein kinase phosphorylation and CD40 ligand/P-selectin expression by cyclic nucleotide-regulated pathways in human platelets. Biochem Pharmacol 2000;60:1399-1407
33. Lindemann S, Tolley ND, Eyre JR, et al. Integrins regulate the intracellular distribution of eukaryotic initiation factor 4E in platelets. A checkpoint for translational control. J Biol Chem 2001;276:33947-33951
34. Weyrich AS, Lindemann S, Tolley ND, et al. Change in protein phenotype without a nucleus: translational control in platelets. Semin Thromb Hemost 2004;30:491-498
35. Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg 2004;114: 1502-1508
36. Nakazawa T, Yasuhara H, Shigematsu K, et al. Smooth muscle cell migration induced by shear-loaded platelets and endothelial cells. Enhanced platelet-derived growth factor production by shear-loaded platelets. Int Angiol 2000;19: 142-146
37. Frenette PS, Moyna C, Hartwell DW, et al. Platelet-endothelial interactions in inflamed mesenteric venules. Blood 1998;91:1318-1324
38. Massberg S, Enders G, Matos FC, et al. Fibrinogen deposition at the postischemic vessel wall promotes platelet adhesion during ischemia-reperfasion in vivo. Blood 1999;94: 3829-3838
39. Romo GM, Dong JF, Schade AJ, et al. The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med 1999;190:803-814
40. Frenette PS, Denis CV, Weiss L, et al. P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J Exp Med 2000;191:1413-1422
41. Gawaz M, Neumann FJ, Dickfeld T, et al. Vitronectin receptor (alpha(v)beta3) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction. Circulation 1997;96: 1809-1818
42. Langer H, May AE, Bultmann A, et al. ADAM 15 is an adhesion receptor for platelet GPIIb-IIIa and induces platelet activation. Thromb Haemost 2005;94:555-561
43. Herren B, Raines EW, Ross R. Expression of a disintegrin-like protein in cultured human vascular cells and in vivo. FASEB J 1997;11:173-180
44. Horiuchi K, Weskamp G, Lum L, et al. Potential role for ADAM15 in pathological neovascularization in mice. Mol Cell Biol 2003;23:5614-5624
45. Lindemann S, Tolley ND, Dixon DA, et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol 2001;154:485-490
46. May AE, Kalsch T, Massberg S, et al. Engagement of glycoprotein IIb/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells. Circulation 2002;106: 2111-2117
47. Slupsky JR, Kalbas M, Willuweit A, et al. Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40. Thromb Haemost 1998;80:1008-1014
48. Gawaz M, Neumann FJ, Dickfeld T, et al. Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation 1998;98:1164-1171
49. May AE, Kalsch T, Massberg S, et al. Engagement of glycoprotein IIb/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells. Circulation 2002;106: 2111-2117
50. Inwald DP, McDowall A, Peters MJ, et al. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 2003;92:1041-1048
51. Frenette PS, Johnson RC, Hynes RO, et al. Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc Natl Acad Sci USA 1995;92: 7450-7454
52. Andre P, Denis CV, Ware J, et al. Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins. Blood 2000;96:3322-3328
53. Johnson RC, Chapman SM, Dong ZM, et al. Absence of P-selectin delays fatty streak formation in mice. J Clin Invest 1997;99:1037-1043
54. Dong ZM, Brown AA, Wagner DD. Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. Circulation 2000;101:2290-2295
55. Burger PC, Wagner DD. Platelet P-selectin facilitates atherosclerotic lesion development. Blood 2003;101:2661-2666
56. Massberg S, Brand K, Gruner S, et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 2002;196:887-896
57. Theilmeier G, Michiels C, Spaepen E, et al. Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia. Blood 2002;99: 4486-4493
58. Cherian P, Hankey GJ, Eikelboom JW, et al. Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes. Stroke 2003;34:2132-2137
59. Berndt MC. Induction of platelet-endothelial interactions in postcapillary venules in hypercholesterolemia: critical
60. role of P-selectin. Arterioscler Thromb Vasc Biol 2003;23: 525-527
61. Berger G, Hartwell DW, Wagner DD. P-selectin and platelet clearance. Blood 1998;92:4446-4452
62. Davi G, Romano M, Mezzetti A, et al. Increased levels of soluble P-selectin in hypercholesterolemic patients. Circulation 1998;97:953-957
63. Andre P, Hartwell D, Hrachovinova I, et al. Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci USA 2000;97:13835-13840
64. Massberg S, Schulz C, Gawaz M. Role of platelets in the pathophysiology of acute coronary syndrome. Semin Vasc Med 2003;3:147-162
65. Neumann FJ, Blasini R, Schmitt C, et al. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation 1998;98:2695-2701